OBJECTIVE: We
aimed to quantify the risk of future maternal T2DM in women with GDM based on
the type and number of abnormal 75g-OGTT values and the diagnostic criteria
used for the diagnosis of GDM.
<p>RESEARCH
DESIGN AND METHODS: We conducted a population-based
retrospective cohort study of all nulliparous women with a live singleton birth
who underwent testing for GDM using a 75g-OGTT in Ontario, Canada (2007-2017).
We estimated the incidence rates (per 1000 person years), overall risk
(expressed as adjusted hazard ratio [aHR]), and risk at 5-year post the index
pregnancy of future maternal T2DM. Estimates were stratified by the type and
number of abnormal OGTT values, as well as by the diagnostic criteria for GDM
(Diabetes Canada vs. IADPSG criteria). </p>
<p>RESULTS: A
total of 55,361 women met the study criteria. The median duration of follow-up
was 4.4 (IQR 2.8-6.3, maximum 10.3) years. Using women without GDM as reference
(incidence rate 2.18 per 1000py), women with GDM were at an increased risk of
future T2DM, with the risk being higher for the Diabetes Canada compared with
the IADPSG criteria (incidence rate 18.74 [95%-CI 17.58-19.90] vs. 14.07 [95%-CI
13.24-14.91] per 1000py, respectively). The risk of future maternal T2DM
increased with the number of abnormal OGTT values, and was highest for women
with 3 abnormal values (incidence rate 49.93 per 1000py; aHR 24.57 [95%-CI
21.26-28.39]). The risk of future T2DM was also affected by the type of OGTT
abnormality: women with an abnormal fasting value had the greatest risk while
women with an abnormal 2-hour value had the lowest risk for future T2DM (aHR
14.09 [95%-CI 12.46-15.93) vs. 9.22 [95%-CI 8.19-10.37]), respectively). <a></a><a>Similar
findings to those described above were observed when the risk of T2DM at a
fixed time point of 5-years post the index pregnancy was considered as the
outcome of interest</a>.</p>
<p>CONCLUSION: In women
with GDM, individualized information regarding the future risk of T2DM can be provided
based on the type and number of abnormal OGTT values, as well as the diagnostic
criteria used for the diagnosis of GDM. </p>